Earnings Call · Q3 FY2025·2025-11-07

Q3 25EPS +7.69%·Rev n/aQ2 25EPS +4.23%·Rev n/aQ1 25EPS +3.33%·Rev n/aQ4 24EPS +9.60%·Rev n/a⚠ consensus missing

Pacira BioSciences, Inc. PCRX

Susan Mesco — Investor Relations

Frank Lee — Chief Executive Officer

Brendan Teehan — Chief Commercial Officer

Shawn Cross — Chief Financial Officer

+4.5%1d on move date+4.4% vs SPY3d+14.3%5d+11.9%

Research tier

Behavioral profile computed for 4 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more PCRX calls or request research access.

More PCRX calls Browse calls Request research access